Form 4: Cardinal Health Director Receives RSU Grant

Sentiment:

Insider Transaction Report 6 November 2025 4:10 PM

Cardinal Health director Michelle Brennan was granted 1,067 restricted share units, increasing her direct beneficial ownership to 8,086 common shares.

Summary

Michelle Brennan, a Director of Cardinal Health Inc. (CAH), was granted 1,067 restricted share units (RSUs).
This transaction, dated November 5, 2025, increased her direct beneficial ownership of common shares to 8,086.
The RSUs were granted at a price of $0, which is typical for equity compensation.
These restricted share units are scheduled to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs before that date.
An accompanying Limited Power of Attorney, effective May 5, 2025, authorizes designated individuals to file SEC reports on behalf of Michelle Brennan.

Sentiment

Score: 7

Explanation: The grant of restricted share units to a director is a positive event as it aligns the director's long-term interests with those of the shareholders. It's a routine compensation mechanism and indicates continued engagement from the board member.

Positives

The grant of restricted share units aligns the director's interests with those of shareholders, promoting long-term value creation.
Increased insider ownership demonstrates confidence in the company's future prospects.

Future Outlook

Industry Context

This is a routine insider transaction filing for a director's equity compensation, which is a common practice across various industries to align management and director incentives with shareholder interests. It does not provide specific industry-wide insights.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Power of Attorney Grant	Michelle M. Brennan granted a Limited Power of Attorney to several individuals, including the Corporate Secretary, to prepare and file SEC Forms 3, 4, 5, and 144 on her behalf. This streamlines compliance with Section 16(a) of the Exchange Act.	2025-05-05	Enhances efficiency and ensures timely compliance with SEC reporting requirements for insider transactions, reducing administrative burden on the director while maintaining her ultimate responsibility for compliance.

Stakeholder Impact

Shareholders: The grant of RSUs to a director aligns their interests with shareholders, potentially leading to better long-term decision-making and value creation.

Next Steps

The restricted share units are expected to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs prior to that date.

Key Dates

Date	Description
2025-05-05	Effective date of the Limited Power of Attorney for SEC reporting purposes.
2025-11-05	Date of the grant of 1,067 restricted share units to Michelle Brennan.
2025-11-06	Date the Form 4 was signed and filed.
2026-11-05	Scheduled vesting date for the restricted share units, or earlier if the 2026 Annual Meeting of Shareholders occurs prior to this date.
2028-06-23	Expiration date of the Notary Public's commission for the Limited Power of Attorney.

Recommendation

hold

This Form 4 reports a routine equity compensation grant to a director, which is a standard practice to align interests. It does not contain information significant enough to warrant a change in investment recommendation, but it reinforces a 'hold' stance due to the positive alignment of interests without introducing new material financial data.

Keywords

Cardinal Health, CAH, Michelle Brennan, Form 4, Insider Transaction, Restricted Share Units, RSU Grant, Director Compensation, Equity Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.